Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04826549 · ClinicalTrials.gov registry record
A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application
A clinical trial of Smoking, Cigarette, sponsored by Rose Research Center.
- Completed
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT04826549: Completed study of Smoking, Cigarette, sponsored by Rose Research Center.
NCT04826549 is a study of Smoking, Cigarette that has completed, run by Rose Research Center. The registered enrollment target is 30 participants, below the 533-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04826549, a study of Smoking, Cigarette, has completed, sponsored by Rose Research Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.
Primary Outcome
Determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples.
Conditions Studied
Study Locations (2)
North Carolina
- Rose Research Center - Charlotte
- Rose Research Center - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2021-10-27 |
What the finished NCT04826549 record still lists
NCT04826549 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 533-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Smoking, Cigarette appearing as the primary indexed condition, and to 0 interventions.
NCT04826549 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04826549 about?
NCT04826549 is a clinical study titled "A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application". The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy ...
What is the current status of trial NCT04826549?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-03-22. Estimated completion is 2021-10-27.
What conditions does trial NCT04826549 study?
This clinical trial studies the following conditions: Smoking, Cigarette.
Who is sponsoring clinical trial NCT04826549?
This trial is sponsored by Rose Research Center, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04826549 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking, Cigarette
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04826549's enrollment target sits among peer trials
30 20th of 21 higher than 2 of 21 other Smoking, Cigarette trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking, Cigarette trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
RECRUITING
-
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
RECRUITING · Phase 1
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
Optimizing Tobacco Treatment Delivery for People Living With HIV
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI